Certificate of Free Sale: Bangladesh Embassy Attestation Chain

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

A Certificate of Free Sale (CFS) destined for Bangladesh cannot be simplified with an Apostille. It has to go through the full embassy legalisation chain. Bangladesh is not a party to the 1961 Hague Convention Abolishing the Requirement of Legalisation for Foreign Public Documents, so foreign public documents are not recognised in Bangladesh on the strength of an Apostille, and the document must pass through three segments: notarisation, then the Ministry of Foreign Affairs (or an authorised provincial foreign affairs office), then the Bangladesh embassy in the issuing country. For Class C and Class D, the exercise is repeated for two CFS documents, one from the country of origin and one from the reference country.

The requirement is procedural but not cosmetic. Attestation is the step that turns a certificate issued by a chamber of commerce or a regulator into a document DGDA will accept, and it is also the step that cannot be recovered if the underlying certificate turns out to be wrong.

  • No Apostille. Bangladesh is outside the 1961 Hague Convention, so the short route is unavailable.
  • Three segments. Notary, then foreign ministry or authorised provincial office, then the Bangladesh embassy.
  • Two chains for Class C and D. Country-of-origin CFS and reference-country CFS are attested separately.
  • Originals at final review. The attested original, not a copy, is what the final stage requires.
  • Zero compressibility. Embassy timings follow their own schedule and cannot be accelerated by the applicant.

2. Legal basis

The controlling fact is a treaty status rather than a Bangladeshi regulation. Because Bangladesh is not a member of the Apostille Convention, the simplified certification that would otherwise replace legalisation is not available, and the general path for documents from non-member states applies: notarisation, foreign ministry certification, then embassy legalisation. The registration guideline and the practical submission lists sit on top of that, requiring the CFS to carry Bangladesh embassy attestation and, for Class C and D, requiring both certificates to be attested and the originals to be produced at final review.

MatterContentSource
Bangladesh is not a party to the Hague ConventionBangladesh is not a member of the Apostille Convention (consistent across sources: HCCH list of contracting parties and embassy guidance)Treaty fact
Embassy legalisation requiredDocuments destined for Bangladesh need to be legalised by the embassyAs above
Alternative is MOFA plus embassy legalisationThe general route for non-member states: notary, foreign ministry, embassyAs above
CFS must be attested by the Bangladesh embassyFSC (Bangladesh Embassy attested)Practical estimate
Class C and D: both CFS documents attestedCountry of origin and reference countryPractical estimate
Original required at final reviewOriginal FSC (attested by Bangladesh Embassy)Practical estimate

Two practical consequences follow from the table. The first is that the chain has three separate hand-offs, and each one can reject the document for a defect that the preceding stage did not catch. The second is that the chain ends in an embassy, which means its duration is set by consular workload rather than by the applicant’s schedule.

3. Expert insights

Insight 1: the same Chinese manufacturer can use an Apostille for the Philippines and cannot use one for Bangladesh. China acceded to the 1961 Hague Convention on 8 March 2023. The convention between China and the Philippines entered into force on 7 November 2023, and since then Chinese public documents going to the Philippines need only an Apostille. Bangladesh is not a contracting party, so the same documents going to Bangladesh still require the full three segments. This is the point where experience most reliably produces the wrong answer, because the last project set a precedent that does not travel. The discipline is to check treaty status per destination rather than per document type.

Insight 2: the reference-country CFS is attested in a third country. If the reference country is Germany, notarisation happens in Germany, certification happens before the German competent authority, and legalisation happens at the Bangladesh embassy in Germany. That means two countries, two legalisation chains and two sets of local agents. The two chains can run in parallel, so the schedule impact is limited, but the cost is doubled and the coordination burden is not trivial, because each chain has its own document requirements and its own rejection risks.

Insight 3: the attestation chain is the one element of a Bangladesh project that cannot be compressed at all. A meeting cycle can wait a quarter; documents can be produced at speed; translators can be added. Embassy legalisation proceeds at its own pace regardless. The practical consensus that follows is simple: start the CFS attestation before anything else is discussed, because every other workstream can be compressed and this one cannot. Projects that begin with the technical file and turn to attestation later lose the same weeks twice, once in preparation and once in waiting.

Insight 4: attestation freezes the document. Once the chain is complete, any correction means repeating all three segments. That inverts the normal drafting habit of correcting as you go: the certificate has to be right before it enters the chain, not after.

4. Practical recommendations

GRZAN manages the CFS chain as route one on every Bangladesh project. On the day the project is confirmed we start the country-of-origin CFS application and attestation, and at the same time set out how the reference-country CFS will be obtained where Class C or D applies. Three checks are completed before any document enters the chain: the issue date of the CFS, to avoid a certificate that expires during the process; the product name on the CFS against the name to be registered; and whether the CFS covers every model being registered. All three must pass before attestation begins, because a correction afterwards restarts the entire sequence.

  • Confirm treaty status per destination. Do not carry an Apostille assumption from another market into Bangladesh.
  • Map the three segments before starting. Name the notary, the foreign ministry or authorised provincial office, and the embassy, with contacts for each.
  • Run both chains for Class C and D. Origin and reference country in parallel, with separate owners.
  • Check the certificate, not just the chain. Date, product name and model coverage are the three recurring failures.
  • Plan originals into logistics. Final review needs attested originals, so courier routing is part of the schedule.

5. Verification checklist

  • □ Confirmed that Bangladesh is not a party to the Hague Convention, so no Apostille is used
  • □ Three-segment process planned: notary, foreign ministry or provincial office, Bangladesh embassy
  • □ Both CFS attestation chains started separately for Class C and D
  • □ Issue date, product name and model coverage checked and cleared
  • □ Original document requirements for final review included in the logistics plan
  • □ Chain completion date checked backwards against the quarterly meeting schedule

Regulatory information verified as of 27 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Bangladesh. Our team prepares dossiers to DGDA expectations, manages submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail